Genus Plc Stock Performance
| GENSF Stock | USD 21.01 0.11 0.53% |
The company retains a Market Volatility (i.e., Beta) of 0.34, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genus Plc's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genus Plc is expected to be smaller as well. At this point, Genus plc has a negative expected return of -0.17%. Please make sure to check out Genus Plc's treynor ratio, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Genus plc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Genus plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
| Begin Period Cash Flow | 46 M | |
| Total Cashflows From Investing Activities | -67.2 M |
Genus |
Genus Plc Relative Risk vs. Return Landscape
If you would invest 2,353 in Genus plc on September 12, 2024 and sell it today you would lose (263.00) from holding Genus plc or give up 11.18% of portfolio value over 90 days. Genus plc is currently producing negative expected returns and takes up 1.418% volatility of returns over 90 trading days. Put another way, 12% of traded pink sheets are less volatile than Genus, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Genus Plc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Genus Plc's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Genus plc, and traders can use it to determine the average amount a Genus Plc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1211
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GENSF |
Estimated Market Risk
| 1.42 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.17 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Genus Plc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genus Plc by adding Genus Plc to a well-diversified portfolio.
Genus Plc Fundamentals Growth
Genus Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Genus Plc, and Genus Plc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Genus Pink Sheet performance.
| Return On Equity | 0.0687 | |||
| Return On Asset | 0.0379 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 2.62 B | |||
| Shares Outstanding | 65.77 M | |||
| Price To Earning | 34.61 X | |||
| Price To Book | 3.47 X | |||
| Price To Sales | 4.15 X | |||
| Revenue | 593.4 M | |||
| EBITDA | 93.1 M | |||
| Cash And Equivalents | 38.8 M | |||
| Cash Per Share | 0.59 X | |||
| Total Debt | 182.1 M | |||
| Debt To Equity | 0.39 % | |||
| Book Value Per Share | 8.85 X | |||
| Cash Flow From Operations | 34.3 M | |||
| Earnings Per Share | 0.75 X | |||
| Total Asset | 1.02 B | |||
| Retained Earnings | (119.78 M) | |||
| Current Asset | 216.1 M | |||
| Current Liabilities | 77.4 M | |||
About Genus Plc Performance
By analyzing Genus Plc's fundamental ratios, stakeholders can gain valuable insights into Genus Plc's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Genus Plc has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Genus Plc has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom. Genus Plc operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3500 people.Things to note about Genus plc performance evaluation
Checking the ongoing alerts about Genus Plc for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Genus plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Genus plc generated a negative expected return over the last 90 days | |
| About 72.0% of the company shares are owned by institutional investors |
- Analyzing Genus Plc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Genus Plc's stock is overvalued or undervalued compared to its peers.
- Examining Genus Plc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Genus Plc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Genus Plc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Genus Plc's pink sheet. These opinions can provide insight into Genus Plc's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Genus Pink Sheet analysis
When running Genus Plc's price analysis, check to measure Genus Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genus Plc is operating at the current time. Most of Genus Plc's value examination focuses on studying past and present price action to predict the probability of Genus Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genus Plc's price. Additionally, you may evaluate how the addition of Genus Plc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |